AT369361B - Verfahren zur herstellung von neuer 4-(3-(3(2-(1-hydroxycyclohexyl)-aethyl)-4-oxo-2thiazolidinyl)-propyl)-benzoes[ure - Google Patents

Verfahren zur herstellung von neuer 4-(3-(3(2-(1-hydroxycyclohexyl)-aethyl)-4-oxo-2thiazolidinyl)-propyl)-benzoes[ure

Info

Publication number
AT369361B
AT369361B AT0766078A AT766078A AT369361B AT 369361 B AT369361 B AT 369361B AT 0766078 A AT0766078 A AT 0766078A AT 766078 A AT766078 A AT 766078A AT 369361 B AT369361 B AT 369361B
Authority
AT
Austria
Prior art keywords
benzoes
hydroxycyclohexyl
ure
oxo
propyl
Prior art date
Application number
AT0766078A
Other languages
English (en)
Other versions
ATA766078A (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA766078A publication Critical patent/ATA766078A/de
Application granted granted Critical
Publication of AT369361B publication Critical patent/AT369361B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/62—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT0766078A 1977-10-27 1978-10-25 Verfahren zur herstellung von neuer 4-(3-(3(2-(1-hydroxycyclohexyl)-aethyl)-4-oxo-2thiazolidinyl)-propyl)-benzoes[ure AT369361B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84606577A 1977-10-27 1977-10-27
US05/847,063 US4130566A (en) 1977-10-27 1977-10-28 Process for producing 5-carboxy-2-acetylthiophene
US05/938,129 US4225609A (en) 1977-10-27 1978-08-30 Interphenylene 9-thia-11-oxo-12-aza-prostanoic acids

Publications (2)

Publication Number Publication Date
ATA766078A ATA766078A (de) 1982-05-15
AT369361B true AT369361B (de) 1982-12-27

Family

ID=27420322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0766078A AT369361B (de) 1977-10-27 1978-10-25 Verfahren zur herstellung von neuer 4-(3-(3(2-(1-hydroxycyclohexyl)-aethyl)-4-oxo-2thiazolidinyl)-propyl)-benzoes[ure

Country Status (6)

Country Link
US (2) US4130566A (de)
EP (1) EP0001900B1 (de)
JP (1) JPS5481267A (de)
AT (1) AT369361B (de)
AU (1) AU520784B2 (de)
CA (1) CA1124245A (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379792A (en) * 1980-10-30 1983-04-12 Merck & Co., Inc. Anti-inflammatory composition
US4390703A (en) * 1981-06-22 1983-06-28 Merck & Co., Inc. Intermediates for the resolution of some interphenylene-9-thia-11-oxo-12-azaprostanoic acids
US4389525A (en) * 1981-06-22 1983-06-21 Merck & Co., Inc. Process for the resolution of some interphenylene 9-thia-11-oxo-12-azaprostanoic acids
US4535164A (en) * 1981-10-19 1985-08-13 Merck & Co., Inc. Process for preparing certain substituted 4-thiazolidinones
ATE26797T1 (de) * 1983-01-24 1987-05-15 Merck & Co Inc Entzuendungshemmende zusammensetzung.
US4472384A (en) * 1983-06-15 1984-09-18 Merck & Co., Inc. Antihypertensive composition
US4639460A (en) * 1985-08-05 1987-01-27 Chevron Research Company Fungicidal substituted N-(1-iodopropargyl)thiazolidinones
US5078659A (en) * 1989-12-11 1992-01-07 Unipat Ag Variable speed transaxle
US5549974A (en) * 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
BRPI0014869B8 (pt) * 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US7985767B2 (en) * 2006-09-06 2011-07-26 Allergan, Inc. Therapeutic amides
US7781465B2 (en) * 2007-08-21 2010-08-24 Allergan, Inc. Therapeutic oxazolidinones and thiazolidinones
US8198318B2 (en) * 2008-03-18 2012-06-12 Allergen, Inc. Therapeutic amides
EP2104299B1 (de) 2008-03-21 2018-05-30 LG Electronics Inc. Verfahren zur Verarbeitung von Daten in einem Internetprotokoll-Fernsehsystem
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CN108658876A (zh) 2012-12-17 2018-10-16 帕里昂科学公司 3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
CN105073717B (zh) 2012-12-17 2018-05-22 帕里昂科学公司 可用于治疗由黏膜水化不足造成的疾病的氯-吡嗪甲酰胺衍生物
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
CN104356126A (zh) * 2014-11-25 2015-02-18 河北科技大学 盐酸阿罗洛尔的制备方法
CN104370900B (zh) * 2014-11-25 2015-12-02 石家庄格瑞药业有限公司 一种盐酸阿罗洛尔的制备方法
CN104530033B (zh) * 2014-12-26 2017-07-07 江西百神药业股份有限公司 一种盐酸阿罗洛尔的制备工艺新方法
MA42683A (fr) 2015-08-27 2018-07-04 Genentech Inc Composés thérapeutiques et leurs méthodes utilisation
JP2018535234A (ja) 2015-11-25 2018-11-29 ジェネンテック， インコーポレイテッド ナトリウムチャネル遮断薬として有用な置換ベンズアミド
WO2017172802A1 (en) 2016-03-30 2017-10-05 Genentech, Inc. Substituted benzamides and methods of use thereof
SG11201903348UA (en) 2016-10-17 2019-05-30 Genentech Inc Therapeutic compounds and methods of use thereof
CN110546148A (zh) 2017-03-24 2019-12-06 基因泰克公司 作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
EP3759098A1 (de) 2018-02-26 2021-01-06 Genentech, Inc. Pyridinsulfonamidverbindungen und deren verwendung gegen schmerz und verwandte störungen
CN111936494A (zh) 2018-03-30 2020-11-13 豪夫迈·罗氏有限公司 作为钠通道抑制剂的取代的氢-吡啶并-吖嗪
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2678929A (en) * 1950-10-19 1954-05-18 Abbott Lab 4-thiazolidone-2-n-caproic acid and salts and method of preparing
US2617808A (en) * 1951-03-31 1952-11-11 Abbott Lab 4-thiazolidone-2-n-caproates and preparation thereof
DE2422498A1 (de) 1973-05-18 1974-12-05 Ciba Geigy Ag Neue thiaprostaglandine und verfahren zu ihrer herstellung
US3883659A (en) * 1973-05-18 1975-05-13 Ciba Geigy Corp 9-Oxaprostaglandin compositions
US3881017A (en) * 1973-05-18 1975-04-29 Ciba Geigy Corp 9-Thiaprostaglandin compositions
HU169072B (de) 1974-05-14 1976-09-28
US4059587A (en) * 1976-05-24 1977-11-22 Merck & Co., Inc. Certain thiazolidine compounds
US4022794A (en) * 1976-05-24 1977-05-10 Merck & Co., Inc. Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof

Also Published As

Publication number Publication date
AU4082078A (en) 1980-04-24
ATA766078A (de) 1982-05-15
US4225609A (en) 1980-09-30
JPS5481267A (en) 1979-06-28
AU520784B2 (en) 1982-02-25
CA1124245A (en) 1982-05-25
EP0001900B1 (de) 1982-04-07
US4130566A (en) 1978-12-19
EP0001900A1 (de) 1979-05-16

Similar Documents

Publication Publication Date Title
AT369361B (de) Verfahren zur herstellung von neuer 4-(3-(3(2-(1-hydroxycyclohexyl)-aethyl)-4-oxo-2thiazolidinyl)-propyl)-benzoes[ure
ATA39879A (de) Verfahren zur herstellung neuer 2-(2-methoxy-4-
AT374187B (de) Verfahren zur herstellung neuer 4-((3,4-dialkoxyphenyl)- alkyl)-2-imidazol idinon-derivaten
AT374194B (de) Verfahren zur herstellung des neuen 2-(2-thenoylthio)-propionylglycin
AT362777B (de) Verfahren zur herstellung von 4-(6'-methoxy-2'naphthyl)-butan-2-on
AT374474B (de) Verfahren zur herstellung von neuen piperidinverbindungen
AT376220B (de) Verfahren zur herstellung neuer 1,4-dihydropyridinderivate
ATA703179A (de) Verfahren zur herstellung von 1,2,3-thiadiazol -5-yl-harnstoffen
AT377262B (de) Verfahren zur herstellung des neuen 2-(3-(4-
AT354421B (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxy- propoxyphenyl)-acrylsaeurederivaten
AT371482B (de) Verfahren zur herstellung von neuen 4-(substituierten) thio-1-b-d-
ATA191279A (de) Verfahren zur herstellung von 25,26-dihydroxycholesterin
ATA710978A (de) Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine
AT367026B (de) Verfahren zur herstellung von 2-(2-hydroxyaethoxy) aethyl-n-(alpha,alpha,alpha-trifluor-m-tolyl) anthranilat
AT365167B (de) Verfahren zur herstellung von alpha-(4-(4-
AT356672B (de) Verfahren zur herstellung von neuen 5(6)- substituierten benzimidazol-2-methylcarbamaten
AT364834B (de) Verfahren zur herstellung von neuen pyronderivaten
AT357547B (de) Verfahren zur herstellung von 3-phenyl- pyridazon-(6)
AT356657B (de) Verfahren zur herstellung von 2,6-methano-3- -benzazocinen
AT375657B (de) Verfahren zur herstellung neuer derivate von 4-(3-(4-chinolyl)-propyl)-piperidin
AT377978B (de) Verfahren zur herstellung neuer 2-(2-methoxy-4amino-5-alkylsulfonyl-benzamidomethyl)pyrrolidine
AT367417B (de) Verfahren zur herstellung eines neuen 3,4dihydroxyzimtaldehydderivates
ATA415383A (de) Verfahren zur herstellung neuer 2-hydroxymethyl-3,4,5-trihydroxypiperidinderiva e
AT361001B (de) Verfahren zur herstellung von neuem racemischem 3-(2-(3-tert.-butylamino-2-hydroxypropoxy)- -phenyl)-6-hydrazinopyridazin-dihydrochlorid- monohydrat
ATA836778A (de) Verfahren zur herstellung von neuen 2-(2',2'-di -dichlorvinyl)-cyclobutanonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee